Track the 武田薬品工業株式会社 share price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Market capitalisation: €9,018.5bn. The latest transaction was reported on 19 September 2025 (Holding update). Among the most active insiders: Sumitomo Mitsui Trust Asset Management Co.,Ltd.. The full history is openly available.
Analysts rate 武田薬品工業株式会社 Buy (bullish), based on 16 analysts. Average price target: JP¥6,263.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
武田药品工业株式会社是一家日本制药公司,专注于药品的研发和销售。该公司在东京证券交易所上市,股票代码为 XTKS。